MoneyWorks4Me

Jubilant Life Sciences board to consider dividend

28 Apr 2012 Evaluate

Jubilant Life Sciences has informed that a meeting of the board of directors of the company will be held on May 07, 2012, to consider the audited financial results of the company for the year ended March 31, 2012 and for recommendation of dividend for the year ended March 31, 2012.

The above information is part of company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1872.90
Dr. Reddys Labs. 1208.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1155.90
View more..